Intriguingly, a recent cohort study of 1339 biopsy-proven NAFLD Caucasian patients (195 lean, BMI < 25 kg/m2) showed that NAFLD development and progression in lean individuals were independent of their PNPLA3 genotype [82]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.